Backgound: At the end of 2019 the emergence of COVID-19 has become a major concern of global health problems, spreading very quickly with significant morbidity and mortality worldwide. Diabetes mellitus was associated about two-fold increased risk of having greater disease severity or death among COVID-19 patients. Appropriate medical treatment needs to be given to Covid-19 patients with co-morbid diabetes mellitus. Objective: In this research we analyzed the profile of Covid-19 with comorbid diabetes mellitus patients admitted in Dr. Soetomo General Hospital Mei-October 2020 Materials and Methods: This research is an retrospective descriptive research using a cross-sectional design. Data was taken using secondary data from medical record Result: In total, 99 patient meet the inclussion criteria. Men (51,5%) in 50-60 years old are the majority subject of this study. There were 56 patients who survived compared to 43 who died. There were 15 patient in critical degree compared to 84 patients that are not in critical. For laboratory finding, the patients mean HbA1c was 9,22% and the mean random blood sugar level was 282 mg/dL. For CBC, there was increased in neutrophils count and NLR, also there was decreased in lymphocytes count. Conclusion: The majority of patient are men over 50 years old, with an abnormal in laboratory finding.

Clinical profile

COVID-19

Diabetes Mellitus